Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Jan;7(1):37-47.
doi: 10.1593/neo.04337.

Association between pterostilbene and quercetin inhibits metastatic activity of B16 melanoma

Affiliations

Association between pterostilbene and quercetin inhibits metastatic activity of B16 melanoma

Paula Ferrer et al. Neoplasia. 2005 Jan.

Abstract

Inhibition of cancer growth by resveratrol (trans-3,5,4'-trihydroxystilbene; RESV), a phytoalexin present in many plant species, is limited by its low bioavailability. Pterostilbene (3,5-dimethoxy-4'-hydroxystilbene; PTER) and quercetin (3,3',4',5,6-pentahydroxyflavone; QUER), two structurally related and naturally occurring small polyphenols, show longer half-life in vivo. In vitro growth of highly malignant B16 melanoma F10 cells (B16M-F10) is inhibited (56%) by short-time exposure (60 min/day) to PTER (40 microm) and QUER (20 microm) (approximate mean values of plasma concentrations measured within the first hour after intravenous administration of 20 mg/kg each polyphenol). Intravenous administration of PTER and QUER (20 mg/kg per day) to mice inhibits (73%) metastatic growth of B16M-F10 cell in the liver, a common site for metastasis development. The anti-metastatic mechanism involves: 1) a PTER-induced inhibition of vascular adhesion molecule 1 expression in the hepatic sinusoidal endothelium, which consequently decreases B16M-F10 cell adhesion to the endothelium through very late activation antigen 4; and 2) a QUER- and PTER-induced inhibition of Bcl-2 expression in metastatic cells, which sensitizes them to vascular endothelium-induced cytotoxicity. Our findings demonstrate that the association of PTER and QUER inhibits metastatic melanoma growth and extends host survival.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Plasma levels and half-life of pterostilbene and quercetin after their intravenous administration to mice. Animals were treated with 20 mg of t-PTER or QUER per kilogram body weight. Plasma levels were determined as explained under Materials and Methods section. Results are mean ± SD for five to six mice per time point.
Figure 2
Figure 2
In vitro inhibition of B16M-F10 cell growth by short-time exposure to resveratrol, pterostilbene, and/or quercetin. B16M-F10 cells were cultured for 72 hours. t-RESV (12 µM), t-PTER (40 µM), and QUER (20 µM) were added at 6, 30, and 54 hours of culture time, and were present each time for only 60 minutes. After the 60-minute period in the presence of polyphenols, the culture flasks were washed out (three times with PBS) and the medium was renewed. All points are mean ± SD for five to six independent experiments. *P < .05, **P < .01 compared to control values.
Figure 3
Figure 3
Flow cytometric analysis of VCAM-1 on HSE cells. Flow cytometry was performed (see the legend to Table 4) on cultured endothelial cells incubated in the absence or in the presence of t-PTER (40 µM). Black histogram: control cells. Grey histogram: t-PTER-treated cells. Results shown are representative of five different experiments.
Figure 4
Figure 4
Western blot analysis of Bcl-2 in B16M-F10 cells. B16M-F10 cells were cultured x 72 hours in the absence or in the presence of t-PTER (40 µM) or QUER (20 µM) (see the legend to Table 6). Lane a, QUER; lane b, t-PTER; lane c, control untreated cells.

References

    1. Yang CS, Landau JM, Huang MT, Newmark HL. Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu Rev Nutr. 2001;21:381–406. - PubMed
    1. Ross JA, Kasum CM. Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu Rev Nutr. 2002;22:19–34. - PubMed
    1. Pervaiz S. Resveratrol: from grapevines to mammalian biology. FASEB J. 2003;17:1975–1985. - PubMed
    1. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science. 1997;275:218–220. - PubMed
    1. Fontecave M, Lepoivre M, Elleingand E, Gerez C, Guittet O. Resveratrol, a remarkable inhibitor of ribonucleotide reductase. FEBS Lett. 1998;421:277–279. - PubMed

Publication types

MeSH terms